Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2026-01-04 @ 4:20 PM
Study NCT ID:
NCT03738150
Status:
COMPLETED
Last Update Posted:
2024-08-27
First Post:
2018-11-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Sponsor:
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-22
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-02
First Submit QC Date:
None
Study First Post Date:
2018-11-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-20
Results First Submit QC Date:
None
Results First Post Date:
2023-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-31
Last Update Post Date:
2024-08-27
Last Update Post Date Type:
ACTUAL